A Pharmacogenomic Exploration of Lacosamide Response

Inclusion Criteria

• •Diagnosed with partial onset seizures (simple and/or complex) with or without secondary generalization (based on 1981 ILAE seizure classification scheme)
• •Over 18 and under 65 years of age at date of recruitment in to the study
• •Currently undergoing pharmacological treatment for refractory partial epilepsy ('refractory' here refers to patients who continue to have seizures despite treatment (current) with two or more appropriate anti-epileptic drugs at appropriate doses)
• •Deemed suitable for treatment with lacosamide (following drug guidelines)